US Edition
Published • loading... • Updated
US FDA completes inspection of Anuh Pharma’s Tarapur manufacturing facility
Summary by Express Pharma
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
US FDA completes inspection of Anuh Pharma’s Tarapur manufacturing facility
The US drug regulator has completed an inspection of Anuh Pharma’s manufacturing facilities located at Tarapur MIDC in Maharashtra, according to a regulatory filing by the company with the stock exchanges. The company stated that the inspection was completed with no Form 483 observations issued by the regulator. In its filing, Anuh Pharma said that the outcome of the inspection reaffirms the company’s continued adherence to regulatory and qualit…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
